OpenVSafe by OpenVAERS
Search V-safe

APZ-86642-40603

2 vaccinations 2 coded responses 6 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
945 / CA
Registered
2021-01-11
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-11
    Registered in v-safe
  3. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-11
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  8. 2021-01-20
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-07-12
    Survey response — 6 months, dose 2
    MedDRA: Cough, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Cough, congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-07-12
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  11. 2021-07-15
  12. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: 3 week cold
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Cough, congestion

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: 3 week cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…